Essential thrombocythemia: a rare disease in childhood
AUTOR(ES)
Beatrice, Julia Maimone, Garanito, Marlene Pereira
FONTE
Rev. Bras. Hematol. Hemoter.
DATA DE PUBLICAÇÃO
2013
RESUMO
Essential thrombocythemia is an acquired myeloproliferative disorder characterized by the proliferation of megakaryocytes in bone marrow, leading to a persistent increase in the number of circulating platelets and thus increasing the risk for thrombotic and hemorrhagic events. The disease features leukocytosis, splenomegaly, vascular occlusive events, hemorrhages and vasomotor disorders. The intricate mechanisms underlying the molecular pathogenesis of this disorder are not completely understood and are still a matter of discussion. Essential thrombocythemia is an extremely rare disorder during childhood. We report on a case of essential thrombocythemia in a child and discuss the diagnostic approach and treatment strategy.
Documentos Relacionados
- Urothelial neoplasm of the bladder in childhood and adolescence: a rare disease
- Essential thrombocythemia - a predisponent factor for stroke
- An altered platelet granule glycoprotein in patients with essential thrombocythemia.
- Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
- The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia
